Lesson
Follow Alcohol From Metabolism to Fibrosis
The same exposure can produce reversible steatosis, inflammatory hepatitis, progressive fibrosis, or decompensated cirrhosis depending on host and coexisting disease.
- ADH
- ALDH
- Acetaldehyde
- NADH
- Fibrosis
spectrum mechanism
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Map metabolism
Alcohol dehydrogenase converts ethanol to acetaldehyde, and aldehyde dehydrogenase converts acetaldehyde to acetate. Excess NADH shifts lipid metabolism toward hepatic fat accumulation.
Map cellular injury
Acetaldehyde adducts, oxidative stress, mitochondrial dysfunction, endotoxin signaling, cytokines, and immune activation injure hepatocytes and activate fibrogenesis.
Name the spectrum
Steatosis may improve with abstinence. Steatohepatitis, alcohol-associated hepatitis, fibrosis, cirrhosis, and ACLF reflect progressively different risk states.
Identify modifiers
Female sex, obesity, diabetes, smoking, gastric bypass, genetic susceptibility, malnutrition, and viral or metabolic liver disease increase progression risk.
Quick check
Lesson
Screen Without Stigma and Stage Without Guessing
Neutral questions, validated tools, and context-aware fibrosis testing produce better evidence than appearance or assumptions.
- AUDIT-C
- Standard drink
- PEth
- FIB-4
- Elastography
screening staging
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Use validated screening
AUDIT-C is a brief screen, while the full AUDIT adds consequences and dependence features. A positive screen prompts assessment rather than automatic diagnosis.
Quantify the pattern
Translate beverage size and alcohol content into standard drinks. Capture binge pattern, duration, periods of abstinence, and recent change.
Use biomarkers transparently
PEth, urine EtG or EtS, and other markers have different windows. Explain purpose, consent, false interpretations, and how results will affect care.
Stage fibrosis carefully
FIB-4 and transient elastography are useful, but active inflammation and alcohol-related thrombocytopenia can inflate estimates. Repeat or escalate uncertain results.
Quick check
Lesson
Treat Alcohol Use Disorder as the Disease Driver
Withdrawal management is only the first transition in recovery, not the end of treatment.
- Motivational care
- Medication
- Behavioral therapy
- Community support
- Harm reduction
recovery system
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Center abstinence without blame
Sustained abstinence gives the liver its best chance to recover. Use person-first language and frame recurrence as a signal to intensify treatment rather than discharge the patient.
Use brief intervention
Ask permission, connect alcohol to the patient's goals, assess readiness, offer choices, and agree on a specific next step.
Combine treatments
Medication, cognitive or motivational therapies, peer support, contingency approaches, and social services can reinforce one another.
Close the handoff
Schedule addiction and hepatology follow-up, provide medication supply, address transportation and cost, and name an urgent-contact pathway.
Quick check
Lesson
Prevent Seizure, Delirium, and Oversedation
Withdrawal severity and treatment setting must be predicted before symptoms peak.
- CIWA-Ar
- Seizure
- Delirium
- Benzodiazepine
- Phenobarbital
withdrawal
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Stratify risk
Prior seizure or delirium, repeated withdrawals, older age, severe medical illness, concurrent sedatives, pregnancy, unstable vitals, and poor support increase risk.
Use scales within limits
CIWA-Ar supports symptom-triggered care in communicative patients but is unreliable in delirium, severe illness, intubation, or overlapping HE.
Use benzodiazepines first line
Benzodiazepines prevent seizures and delirium. In significant liver dysfunction, lorazepam or oxazepam reduces dependence on oxidative hepatic metabolism.
Reserve advanced regimens
Phenobarbital requires experienced clinicians and close monitoring. Clonidine, dexmedetomidine, and beta blockers are adjuncts and do not prevent seizures alone.
Quick check
Lesson
Protect the Brain and Rebuild Metabolic Reserve
Thiamine deficiency, electrolyte depletion, sarcopenia, and refeeding risk can coexist before the liver diagnosis is complete.
- Wernicke encephalopathy
- Thiamine
- Magnesium
- Phosphate
- Protein
thiamine nutrition
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Do not wait for the triad
Confusion, ataxia, and ocular findings are the classic Wernicke triad, but many patients do not show all three. Treat promptly when risk and findings support it.
Choose the route from risk
Parenteral thiamine is preferred with malnutrition, malabsorption, critical illness, severe withdrawal, or suspected Wernicke disease. Prevention and treatment doses are not interchangeable.
Correct partners selectively
Check magnesium because it supports thiamine-dependent enzymes. Correct documented severe phosphate, potassium, and magnesium abnormalities with monitoring.
Feed adequately
Many patients need about 35 kcal/kg/day and 1.2 to 1.5 g/kg/day protein. Add supplements and enteral nutrition when oral intake remains inadequate.
Quick check
Lesson
Select Recovery Medication Through Organ Function
The older list of naltrexone, acamprosate, and disulfiram is not a safe menu for every patient with liver disease.
- Acamprosate
- Naltrexone
- Baclofen
- Gabapentin
- Topiramate
aud medications
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Use acamprosate for abstinence support
Acamprosate is renally eliminated and taken three times daily. Reduce the dose in moderate renal impairment and avoid it when creatinine clearance is 30 mL/min or less.
Use naltrexone for heavy-drinking reduction
Oral or extended-release naltrexone can be considered in appropriate compensated ALD. Exclude opioids, acute hepatitis or liver failure, and create a pain plan.
Use baclofen deliberately
Baclofen is off label but has ALD-specific evidence. Start low, titrate gradually, adjust for kidney function, and monitor sedation, falls, and cognition.
Avoid disulfiram in ALD
Current ACG guidance advises against disulfiram across ALD because of hepatotoxicity and limited benefit. Gabapentin or topiramate may be selected off label with CNS and renal safeguards.
Quick check
Lesson
Diagnose Alcohol-Associated Hepatitis as a Syndrome
Acute jaundice after sustained heavy exposure is a clinical pattern that still requires exclusion of competing causes and infection.
- Jaundice
- Bilirubin
- AST and ALT
- Infection
- Biopsy
hepatitis diagnosis
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Recognize the phenotype
Typical AH includes recent onset or worsening jaundice, bilirubin elevation, AST greater than ALT with usually moderate enzyme values, and sustained heavy alcohol exposure.
Exclude alternatives
Review drugs and supplements, viral hepatitis, biliary obstruction, ischemia, autoimmune disease, sepsis, vascular disease, and metabolic injury.
Search complications
Assess ascites with diagnostic paracentesis when indicated, cultures and imaging from presentation, AKI, bleeding, HE, nutrition, and ACLF.
Use biopsy selectively
Biopsy is not required for a classic high-confidence presentation but may be useful when uncertainty would change corticosteroid or transplant decisions.
Quick check
Lesson
Make Corticosteroid Exposure Earn Its Risk
Prednisolone benefits a selected severe-AH subgroup only when contraindications are controlled and early response is demonstrated.
- MELD
- Maddrey DF
- Prednisolone
- Lille
- Infection
steroid lille
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Use current severity framing
Current ACG guidance uses MELD above 20 to define severe AH for corticosteroid consideration. Maddrey DF remains familiar but is laboratory dependent.
Screen contraindications
Evaluate uncontrolled infection, active GI bleeding, severe kidney failure, pancreatitis, and other steroid hazards. Treated infection may permit later reassessment.
Give the selected regimen
Prednisolone 40 mg daily is the common oral regimen for up to 4 weeks when appropriate. Do not use pentoxifylline as a substitute.
Stop nonresponse
Calculate Lille at day 4 or 7. A score at least 0.45 indicates poor response and generally supports stopping corticosteroids to reduce infection risk.
Quick check
Lesson
Combine Disease Therapy With Organ Support
NAC, nutrition, infection surveillance, kidney protection, and AUD treatment operate alongside corticosteroid selection.
- NAC
- Nutrition
- AKI
- Infection
- ACLF
nac support
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Use NAC as an adjunct
The 2024 ACG guideline recommends intravenous NAC with corticosteroids in severe AH. It is adjunctive rather than a stand-alone cure.
Feed early
Oral nutrition and supplements are preferred. Use enteral feeding when intake remains inadequate, including with stable varices when there is no active bleeding or recent banding contraindication.
Avoid universal antibiotics
Screen carefully and treat documented or strongly suspected infection, but do not give prophylactic antibiotics universally to every severe-AH admission.
Track organ failure
Creatinine, oxygenation, pressure, mental status, infection, bleeding, sodium, and bilirubin trajectory determine ICU, transplant, and palliative pathways.
Quick check
Lesson
Treat Established Cirrhosis in Parallel
Abstinence can improve prognosis, but portal hypertension, ascites, HE, HRS, bleeding, and HCC risk still require full cirrhosis care.
- Ascites
- SBP
- Varices
- HE
- HCC
cirrhosis complications
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Manage fluid and infection
Use diagnostic paracentesis for new or admitted ascites, sodium and diuretic plans, albumin with large-volume paracentesis, and SBP treatment or prophylaxis when indicated.
Prevent bleeding
Assess CSPH and variceal risk for nonselective beta blockade or endoscopic strategy, and use the acute bleeding bundle when hemorrhage occurs.
Protect cognition and kidneys
Treat HE precipitants with lactulose and selected rifaximin, avoid sedative accumulation, and distinguish HRS-AKI from shock or structural kidney disease.
Continue surveillance
Provide HCC surveillance about every 6 months, vaccines, nutrition, bone health, medication stewardship, and timely transplant referral.
Quick check
Lesson
Select Transplant Candidates With Evidence, Not a Calendar
Early transplant can be lifesaving for selected severe-AH nonresponders, and modern evaluation is multidimensional.
- Early transplant
- Relapse risk
- Support
- Insight
- Equity
transplant ethics
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Move beyond six months alone
A fixed six-month abstinence rule does not accurately predict relapse and can exclude patients who will die before reaching it.
Use multidisciplinary evidence
Evaluate prior treatment, relapse pattern, insight, psychiatric disease, other substances, social support, housing, adherence, coping, and willingness to engage.
Plan post-transplant recovery
Continue AUD medication when appropriate, behavioral care, biomarker monitoring with transparency, family support, and rapid intervention for recurrence.
Protect equity
Apply documented center criteria consistently and separate moral judgment from medical and psychosocial risk assessment.
Quick check
Lesson
Build a Closed-Loop Liver and Recovery Plan
The highest-quality plan treats withdrawal, AUD, liver injury, nutrition, complications, and social conditions as one system.
- Withdrawal
- AUD medication
- Liver state
- Nutrition
- Follow-up
integrated case
Connect hepatic injury, withdrawal safety, addiction treatment, nutrition, and long-term recovery without stigma.
Stabilize immediate risk
Assess withdrawal, suicidality, intoxication, trauma, infection, bleeding, glucose, electrolytes, thiamine need, and level of care.
Define liver disease
Document AH confidence, fibrosis, compensation, MELD, organ failures, infection, HCC status, and transplant indication.
Start recovery treatment
Choose medication through liver, kidney, opioid, cognition, and goal context. Add behavioral care and practical support before discharge.
Measure what matters
Track alcohol goals, adherence, recurrence, liver function, nutrition, complications, quality of life, and re-entry without punitive discharge.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.